Lu A Y
Fed Proc. 1976 Nov;35(13):2460-3.
The liver microsomal drug-metabolizing enzyme system consists of two protein components, cytochrome P-450 and NADPH-cytochrome c reductase, and a lipid, phosphatidylcholine. Cytochrome P-450 serves as the binding site for oxygen and substrate while the reductase acts as an electron carrier shuttling electrons from NADPH to cytochrome P-450. The phospholipid facilitates the transfer of electrons from NADPH-cytochrome c reductase to cytochrome P-450 but itself is not an electron carrier. Different cytochromes P-450 and P-448 have been purified; the spectral, catalytic, and immunological properties as well as the molecular weight (determined by SDS-gel electrophoresis) of all these hemeproteins differ from one another. The presence of multiple cytochrome P-450s may explain the species, strain, age, tissue, and sex differences as well as the effect of inducers and nutritional status in mammlian drug metabolism.
肝脏微粒体药物代谢酶系统由两种蛋白质成分,即细胞色素P - 450和NADPH - 细胞色素c还原酶,以及一种脂质,即磷脂酰胆碱组成。细胞色素P - 450作为氧和底物的结合位点,而还原酶则作为电子载体,将电子从NADPH穿梭至细胞色素P - 450。磷脂促进电子从NADPH - 细胞色素c还原酶向细胞色素P - 450的转移,但它本身并非电子载体。不同的细胞色素P - 450和P - 448已被纯化;所有这些血红素蛋白的光谱、催化和免疫特性以及分子量(通过SDS - 凝胶电泳测定)彼此不同。多种细胞色素P - 450的存在可能解释了哺乳动物药物代谢中的物种、品系、年龄、组织和性别差异,以及诱导剂和营养状况的影响。